We will be attending the EFIC Pain conference in Vienna on September 2-5. Click below to set-up a time to talk with our Scientific or Business Development leadership.
Pharmacology Efficacy Studies
With flexibility, well validated models and expertise to provide relevant protocols, we become an extension of your team.
Evaluating Chronic Pain
Do your current preclinical studies reflect the human condition? Large animal models of pain bridge the preclinical/clinical gap.
Senerga® PS is a powerful in vivo platform for identifying pharmaceutically relevant activity of compound libraries.
Rodent and pig models enable rapid screening followed by more clinically relevant studies in the pig.
Your Preclinical CRO Partner
Bringing innovation and new approaches to preclinical study design for biotechology, pharmaceutical and medical device companies world wide. Let's partner together to progress life saving therapies to clinical stages.
In 2011, it was reported that more first-in-class drugs were identified by phenotypic screening than target-based approaches over a decade reviewed. Phenotypic screening enables simultaneous evaluation of multiple...
Large animal models
Increase the probability of drug development success at the preclinical stages. The failure to interpret results from animals to humans using rodent models calls for more predictive models.
There is less than 10% success rate bringing new drugs to market, and many failures can be pointed to lack of safety or efficacy. Working with a partner who understands disease pathology and numerous biological targets is essential to good...
Medical Device Studies
MD Biosciences offers large animal studies for medical device testing in pain, cardiovascular and metabolic therapeutic areas. The pig is an ideal species due to the close resemblance of many target organs to human. Our experience covers...
Interactions between the nervous and immune systems and the potential targets that lie in the overlap.